- Home
- RBB vs CADL Comparison
RBB vs CADL Comparison
Compare RBB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBB
- CADL
- Stock Information
- Founded
- RBB 2008
- CADL 1999
- Country
- RBB United States
- CADL United States
- Employees
- RBB N/A
- CADL N/A
- Industry
- RBB Major Banks
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- RBB Finance
- CADL Health Care
- Exchange
- RBB Nasdaq
- CADL Nasdaq
- Market Cap
- RBB 308.3M
- CADL 306.4M
- IPO Year
- RBB 2017
- CADL 2021
- Fundamental
- Price
- RBB $16.65
- CADL $8.06
- Analyst Decision
- RBB Hold
- CADL Strong Buy
- Analyst Count
- RBB 4
- CADL 4
- Target Price
- RBB $21.25
- CADL $21.00
- AVG Volume (30 Days)
- RBB 30.2K
- CADL 1.2M
- Earning Date
- RBB 04-21-2025
- CADL 03-13-2025
- Dividend Yield
- RBB 3.67%
- CADL N/A
- EPS Growth
- RBB N/A
- CADL N/A
- EPS
- RBB 1.47
- CADL N/A
- Revenue
- RBB $104,842,000.00
- CADL N/A
- Revenue This Year
- RBB $15.69
- CADL N/A
- Revenue Next Year
- RBB $7.66
- CADL N/A
- P/E Ratio
- RBB $11.63
- CADL N/A
- Revenue Growth
- RBB N/A
- CADL N/A
- 52 Week Low
- RBB $16.38
- CADL $1.40
- 52 Week High
- RBB $25.30
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- RBB 33.56
- CADL 45.77
- Support Level
- RBB $16.79
- CADL $8.33
- Resistance Level
- RBB $17.58
- CADL $9.08
- Average True Range (ATR)
- RBB 0.53
- CADL 0.59
- MACD
- RBB 0.06
- CADL -0.04
- Stochastic Oscillator
- RBB 12.36
- CADL 42.70
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.